Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

    Press Releases | January 31, 2022 | OPEN Health

    OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver

    Expanding Access to High-Quality Healthcare

    Videos and Podcasts | January 27, 2022 | Impetus Digital

    Dr. Jason Cross, Co-founder & Chief Strategy Officer at Rymedi, dives into Connected Health, including how it can be used to expand access to high-quality healthcare, current barriers to its...

    ARISE – a strategic healthcare communication planning process from Bedrock

    Press Releases | January 26, 2022 | Bedrock Healthcare Communications

    Bedrock Healthcare Communications MD Marie Little talks through the ARISE process and the clarity it brings to clients.

    Let’s explore new frontiers

    Videos and Podcasts | January 25, 2022 | Oxford PharmaGenesis

    Personalised medicine: driving a need for greater diversity in clinical trials

    White Papers and Resources | January 25, 2022 | Innovative Trials

    Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.

    Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy

    Press Releases | January 24, 2022 | Lucid Group Communications Limited

    We are excited to welcome this year’s cohort of graduates into our Lucid Futures Academy, which is now into its sixth year after being launched in Oct 2017.The Futures Academy...

    Developing Innovative Digital Strategies to Engage Patients

    Videos and Podcasts | January 21, 2022 | Impetus Digital

    Caitlin Wagner, Associate Marketing Director at Pharming, shares her expertise on innovative patient engagement strategies, including the roles of mobile apps and social media, the impact of the COVID-19 pandemic...

    Cervical Cancer Prevention Month

    White Papers and Resources | January 20, 2022 | Innovative Trials

    In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer

    6 critical success factors for flawless execution of a rapid first commercial launch

    White Papers and Resources | January 19, 2022 | Avalere Health

    Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.

    Meet Innovative Trials at SCOPE 2022

    Press Releases | January 18, 2022 | Innovative Trials

    Stop by Booth 1015 to meet the Innovative Trials' team during SCOPE 2022